Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 701,890 |
|
|||||
| News | - | ||||||
| Day High | 2.16 | Low High |
|||||
| Day Low | 1.912 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Mereo BioPharma Group PLC | MREO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.22 | 11.58% | 2.12 | 11:28:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.95 | 1.912 | 2.16 | 1.90 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,042 | 701,890 | $ 2.08 | $ 1,460,295 | - | 0.4945 - 2.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:29:31 | 8 | $ 2.11 | USD |
Mereo BioPharma Group PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 140.18M | - | 811k | -34.2M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mereo BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MREO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.08 | 2.1804 | 1.86 | 1.96 | 828,111 | 0.04 | 1.92% |
| 1 Month | 2.06 | 2.39 | 1.86 | 2.09 | 984,114 | 0.06 | 2.91% |
| 3 Months | 1.39 | 2.39 | 1.07 | 1.74 | 1,256,950 | 0.73 | 52.52% |
| 6 Months | 1.05 | 2.39 | 0.9201 | 1.46 | 1,378,528 | 1.07 | 101.9% |
| 1 Year | 0.7683 | 2.39 | 0.4945 | 1.25 | 1,283,404 | 1.35 | 175.93% |
| 3 Years | 2.38 | 4.7112 | 0.301 | 2.01 | 1,645,137 | -0.26 | -10.92% |
| 5 Years | 6.55 | 6.5659 | 0.301 | 2.04 | 1,119,637 | -4.43 | -67.63% |
Mereo BioPharma Description
| Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. |
